Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

RayStation 4, 4.5, 4.7, 4.9, 5, 6, 7, 8A, 8B, 9A, 9B, RayPlan 1, 2, 7, 8A, 8B, 9A, 9B, including all service packs. RayStation 10A and RayPlan 10A are also affected, but not the 10A service pack. (Model No. 4.0, 4.5, 4.7, 4.9, 5.0, 6.0, 6.1, 6.2, 6.3, 7.0, 8.0, 8.1, 9.0, 9.1, 9.2, 10.0)

FDA Recall Z-0589-2021 · Posted None

Recall StatusTerminated
Product CodeMUJ
Date Initiated2020-11-11
Date Terminated2023-05-09
Product Quantity124

Reason for Recall

Two issues were found with the treatment plan report: 1) There may be incorrect information for the percent of a region of interest with a clinical goal that is outside the dose grid; and 2) For RayStation and RayPlan 9B and 10A, 6D couch angles may be incorrect.

Firm Action

On November 11, 2020, the firm issued Field Safety Notices to affected customers via email. Customers were informed of the affected versions and the product issue. ACTIONS TO BE TAKEN BY THE USER: " Always verify in the RayStation/RayPlan GUI that all relevant regions of interest (ROIs) are within the dose grid. " If using the treatment plan report for evaluation of clinical goal results, verify the percentage outside the dose grid (% outside grid) for each ROI in the RayStation/RayPlan GUI. " In the treatment plan report, be aware that the Couch pitch angle and Couch roll angle values for setup beams may be incorrect. " Use exported DICOM plans, not the treatment plan report, for transferring treatment parameters to the delivery system. " Please educate planning staff and all users about this workaround. " Inspect your product and identify all installed units with the above software version number(s). " Confirm you have read and understood this notice by replying to the notification email. This issue will be resolved in the next version of RayStation and RayPlan, scheduled for market release in November 2020 (subject to market clearance in some markets). If customers wish to continue using versions of RayStation and RayPlan affected by this notice, all users must maintain awareness of this notice. Alternatively, customers can choose to upgrade to the new version once it becomes available for clinical use.

Root Cause

Software design

Distribution Pattern

US Nationwide distribution.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑